PDGFRβ-Antagonistic Affibody-Mediated Tumor-Targeted Tumor Necrosis Factor-Alpha for Enhanced Radiotherapy in Lung Cancer

Author:

Tang Xiaohui1,Chen Jie2,Zhao Zhenxiong3,Liu Jie1,Yu Ranfei1,Zhao Kunlong1,Wang Fei1,Li Yang1,Tian Baoqing1,Yuan Dandan1,Liu Yuguo1,Fan Qing1ORCID

Affiliation:

1. Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, PR China

2. NHC Key Lab of Transplant Engineering and Immunology, West China Hospital, Sichuan University, Chengdu 610041, PR China

3. Taizhou Central Hospital (Taizhou University Hospital), Taizhou 318000, PR China

Funder

Natural Science Foundation of Shandong Province

National Natural Science Foundation of China

Youth Innovation Technology Project of Higher School in Shandong Province

Shandong Traditional Chinese Medicine Science and Technology Project

Publisher

American Chemical Society (ACS)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3